The use of Fetal Bovine Serum in replacement alternative methods is associated with serious animal welfare concerns, as well as worrying reproducibility issues
Get full access to this article
View all access options for this article.
References
1.
JochemsC.E., van der ValkJ.B., StafleuF.R., & BaumansV. (2002). The use of fetal bovine serum: Ethical or scientific problem?ATLA, 30, 219–227.
2.
van der ValkJ., MellorD., BrandsR., FischerR., GruberF., GstraunthalerG., HellebrekersL., HyllnerJ., JonkerF.H., PrietoP., ThalenM., & BaumansV. (2004). The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicology in Vitro18, 1–12.
3.
RussellW.M.S., & BurchR.L. (1959). The Principles of Humane Experimental Technique, 238 pp. London, UK: Methuen.
4.
Anon. (2010). Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European UnionL276, 20.10.2010, 33–79.
MannelloF., & TontiG.A. (2007). Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!Stem Cells, 25, 1603–1609.
7.
BakerM. (2016). Reproducibility: Respect your cells!Nature, London, 537, 433–435.
FangC-Y., WuC-C., FangC-L., ChenW-Y., & ChenC-L. (2017). Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines. PLoS One12, e0178960.
10.
Toohey-KurthK., SibleyS.D., & GoldbergT.L. (2017). Metagenomic assessment of adventitious viruses in commercial bovine sera. Biologicals47, 64–68.
van der ValkJ., BrunnerD., De SmetK., Fex SvenningsenA., HoneggerP., KnudsenL.E., LindlT., NorabergJ., PriceA., ScarinoM.L., & GstraunthalerG. (2010). Optimization of chemically defined cell culture media — replacing fetal bovine serum in mammalian in vitro methods. Toxicology in Vitro24, 1053–1063.
13.
GstraunthalerG., RauchC., FeifelE., & LindlT. (2015). Preparation of platelet lysates for mesen chymal stem cell culture media. Journal of Stem Cells Research, Reviews & Reports2, 1021.
14.
BarnesD., & SatoG. (1980). Methods for growth of cultured cells in serum-free medium. Analytical Biochemistry102, 255–270.
CastroF., DirksW.G., FähnrichS., Hotz-WagenblattA., PawlitaM., & SchmittM. (2013). High-throughput SNP-based authentication of human cell lines. International Journal of Cancer132, 308–314.
18.
GeraghtyR.J., Capes-DavisA., DavisJ.M., DownwardJ., FreshneyR.I., KnezevicI., Lovell-BadgeR., MastersJ.R., MeredithJ., StaceyG.N., ThravesP., & ViasM.; Cancer Research UK (2014). Guidelines for the use of cell lines in biomedical research. British Journal of Cancer111, 1021–1046.
19.
HartungT. (2007). Food for thought… on cell culture. ALTEX24, 143–152.
20.
OECD (undated). Draft Guidance Document on Good In Vitro Method Practices (GIVIMP) for the Development and Implementation of In Vitro Methods for Regulatory Use in Human Safety Assessment, 112 pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/env/ehs/testing/OECD_Draft_GIVIMP_in_Human_Safety_Assessment.pdf (Accessed 01.11. 17).
